Explore News By Topic
Prostate cancer is one of the most heritable forms of cancer. Hereditary mutations in “DNA repair” genes – BRCA1, BRCA2, and others – which are best known for their association with breast and ovarian cancer predisposition, are now known to be associated with advanced prostate cancer. In fact, ~12% of.
Feb. 24, 2015 (HealthDay News) -- U.S. recommendations against the PSA test for prostate cancer might have prompted a small but measurable increase in the number of higher-risk cases diagnosed recently, according to a new study. The U.S. Preventive Services Task Force (USPSTF) in 2009 recommended that the PSA test.
Metastatic Prostate Cancer Cases Skyrocket Increase May Be Due To More Lax Screening Or More Aggressive Disease
Highest increase among men ages 55 to 69, who could benefit the most from screening and early treatment. Disease is more advanced when finally diagnosed. "Screening saves lives," urologists stress. "If I were a patient, I would want to be vigilant." Chicago -- The number of new cases of metastatic.
New Genetic Test Helps To Select Best Medicines For Prostate Cancer Treatment And Identifies Hereditary Cancer Genes
Like self-driving cars, precision medicine for prostate cancer is no promise of the distant future -- with the efforts of Prostate Cancer Foundation (PCF)-funded researchers and others, the prototypes have arrived. The first major precision medicine studies were huge -- utilizing "whole exome" sequencing, in which every gene expressed by.
By Amy Norton HealthDay Reporter MONDAY, April 11, 2016 (HealthDay News) -- Older men who receive testosterone-suppressing therapy for prostate cancer may be at increased risk of developing depression, a new, large study suggests. The findings are based on over 78,000 U.S. men treated for earlier-stage prostate cancer. Researchers found.
By Robert Preidt HealthDay Reporter WEDNESDAY, April 6, 2016 (HealthDay News) -- Higher doses of radiation may not benefit low-risk prostate cancer patients, a new review suggests. "In the field of radiation oncology, we often assume that the highest dose that the body can tolerate will be most effective at.
Mar. 26, 2015 (HealthDay News) -- Fit middle-aged men appear less likely to develop lung and colon cancer in later life than their out-of-shape peers. And if they do develop cancer, they are more likely to beat it, a new study suggests. Nearly 14,000 men underwent treadmill tests at midlife.
TUESDAY, Dec. 15, 2015 (HealthDay News) -- Men with prostate cancer that's still confined to the organ are more likely to survive if they have surgery rather than radiation therapy, a new Canadian study suggests. This type of "localized" prostate cancer is the most common form of the disease, accounting.
Oct. 22, 2015 (HealthDay News) -- Older black men with prostate cancer seem more likely to receive poorer quality of care that costs more compared to white men, a new study found. Although there was no difference between the races in survival from prostate cancer, black men had to wait.
Aug. 5, 2015 (HealthDay News) -- Chemotherapy at the start of hormone therapy can extend the lives of men with prostate cancer that has spread beyond the gland, a new study finds. Over nearly 29 months of follow-up, men with advanced prostate cancer who received the combination therapy lived almost.